Clinical Trials Browser

Phase 1/2 × INDUSTRY × TIC10 compound × Clear all

NCT02863991 2024-07-03

Oral ONC201 in Relapsed/Refractory Multiple Myeloma

Phase 1/2 Terminated

17 enrolled 10 charts

Multiple Myeloma

NCT02038699 2021-04-30

A First-in-man Phase I/II Study of Oral ONC201 in Patients With Advanced Cancer

Phase 1/2 Withdrawn

BreastCNSGastrointestinalThoracic

Advanced Glioblastoma